openPR Logo
Press release

Oxytocic Pharmaceuticals Market Growth, Trends and Value Chain 2016-2026 by FMI

07-26-2016 10:12 AM CET | Health & Medicine

Press release from: Future Market Insights

Oxytocic Pharmaceuticals Market Growth, Trends and Value Chain

Oxytocin is a female reproductive hormone which is secreted in hypothalamus and is released into the bloodstream during a childbirth to induce a labor and milk production in the lactating mother. Oxytocic drugs as a medication, can be used as an uterotonic i.e. as an agent to induce uterine contractions (induced labor) and to reduce hemorrhage after C-section. Besides, oxytocic drugs are also given in conditions such as uterine atony, post-mature birth, pre-eclampsia (hypertension in pregnancy), postpartum hemorrhage, stillbirth (death of baby in uterus), as an adjunct therapy in case of incomplete abortion and treatment of autism. Oxytocic drugs are also used in veterinary medicine. Endogenously secreted oxytocin manifests its effects towards the end of pregnancy, during child birth and just after delivery. Synthetic oxytocic drugs are devoid of antidiuretic activity due to absence of vasopressin. According to World Health Organization’s (WHO) preterm birth fact sheet 2015, each year 15 Mn babies are born prematurely across the globe and the number is on rise. As per National Center for Health Statistics, U.S. reported 23.3% labor induction rate in 2012.

Oxytocic Pharmaceuticals Market: Drivers and Restraints

Increasing number of preterm births and rising labor induction rates are the primary factors responsible for the growth of global oxytocic pharmaceuticals market. Moreover, ascending cases of pregnancy related complications in developing countries, expanding use of oxytocic drugs in animals etc. are some other factors fueling the growth of global market for oxytocic pharmaceuticals. However, side effects and risks related to oxytocic drugs can be the only restraint for the growth of global oxytocic pharmaceuticals market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1445

Oxytocic Pharmaceuticals Market: Segmentation

The global oxytocic market is classified on the basis of product type, source of origin, end use and geography.

Based on product type, the global oxytocic market has been segmented as follows:

Intravenous Infusion/Injection

Intramuscular Injection

Based on source of origin, the global oxytocic market has been segmented as follows:

Synthetic Oxytocin Derivative

Natural Oxytocin (animal pituitary extracts)

Based on end use, the global oxytocic market is segmented as follows:

Hospitals

Maternity Clinics

Oxytocic Pharmaceuticals Market: Overview

Numerous oxytocic product offerings from various companies including the brands such as Evatocin, Pitogin, Octocin, Syntocinon, Tiacinon, Cytotec, Duratocin and Pitocin are competing to capture the market share in the global market for oxytocic pharmaceutical markets. Synthetic oxytocin derivatives segment is expected to contribute maximum share owing to easy availability of products. Hospital end user segment is anticipated to hold foremost share due to requirement of advanced healthcare infrastructure.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1445

Oxytocic Pharmaceuticals Market: Region-wise Outlook

Geographically, the global oxytocic pharmaceuticals market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate the global market for oxytocic pharmaceuticals market owing to high rate for induced labor. Europe is anticipated to rank second in global oxytocic market due to increase in oxytocin administration with rising number of elective caesareans. As per NHS data, induction rate in England has increased from 22.1% in 2012 to 25.0% in 2014. Increasing number of cases for C-sections in countries such as India, China is expected to fuel the growth of oxytocic pharmaceutical market in Asia Pacific region.

Oxytocic Pharmaceuticals Market: Key Players

The global oxytocic pharmaceuticals market is dominated by Fresenius Kabi AG, LBS Labs, Biofutura Pharma SpA, APP Pharmaceuticals, LLC, JHP Pharmaceuticals, LLC, Baxter Healthcare Corporation, Pfizer Inc., Ferring B.V., Par Pharmaceutical, Inc. and others.

Browse Full Report@ http://www.futuremarketinsights.com/reports/oxytocic-pharmaceuticals-market

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oxytocic Pharmaceuticals Market Growth, Trends and Value Chain 2016-2026 by FMI here

News-ID: 351714 • Views:

More Releases from Future Market Insights

AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Rising Digital Transformation
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Advanced Technology Integration
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels. As e-commerce continues to penetrate global
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Technological Innovation
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications. The expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Security Infrastructure Expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the